Procter & Gamble Health Limited

NSE PGHL.NS

Procter & Gamble Health Limited Net Cash Used For Investing Activities for the year ending June 30, 2024: USD -824.40 K

Procter & Gamble Health Limited Net Cash Used For Investing Activities is USD -824.40 K for the year ending June 30, 2024, a 68.53% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Procter & Gamble Health Limited Net Cash Used For Investing Activities for the year ending June 30, 2023 was USD -2.62 M, a 18.97% change year over year.
  • Procter & Gamble Health Limited Net Cash Used For Investing Activities for the year ending June 30, 2022 was USD -3.23 M, a 25.49% change year over year.
  • Procter & Gamble Health Limited Net Cash Used For Investing Activities for the year ending June 30, 2021 was USD -4.34 M, a -131.51% change year over year.
  • Procter & Gamble Health Limited Net Cash Used For Investing Activities for the year ending June 30, 2020 was USD 13.77 M, a -92.44% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
NSE: PGHL.NS

Procter & Gamble Health Limited

CEO Mr. Milind Vasant Thatte M.B.A.
IPO Date July 1, 2002
Location India
Headquarters Godrej One
Employees 1,407
Sector Health Care
Industries
Description

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Similar companies

SANOFI.NS

Sanofi India Limited

USD 63.68

0.49%

ABBOTINDIA.NS

Abbott India Limited

USD 301.67

0.10%

ASTRAZEN.NS

AstraZeneca Pharma India Limited

USD 83.39

-0.45%

PGHH.NS

Procter & Gamble Hygiene and Health Care Limited

USD 167.13

0.62%

PFIZER.NS

Pfizer Limited

USD 52.31

0.35%

StockViz Staff

February 1, 2025

Any question? Send us an email